Cargando…

Impact attenuation provided by older adult protective headwear products during simulated fall-related head impacts

INTRODUCTION: While protective headwear products (PHP) are designed to protect older adults from fall-related head injuries, there are limited data on their protective capacity. This study’s goal was to assess the impact attenuation provided by commercially available PHP during simulated head impact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martel, Daniel R, Tanel, Michelle R, Laing, Andrew C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	AGE-WELL Standard Submission
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645304/ https://www.ncbi.nlm.nih.gov/pubmed/34877017 http://dx.doi.org/10.1177/20556683211050357

Ejemplares similares

Development of a stick-on hip protector: A multiple methods study to improve hip protector design for older adults in the acute care environment
por: Post, E, et al.
Publicado: (2019)

Potential assistive technology preferences of informal caregivers of people with disability
por: Atoyebi, Oladele, et al.
Publicado: (2023)

Ethical research engagement with Indigenous communities
por: Billan, Jennifer, et al.
Publicado: (2020)

Joining semantic and augmented reality to design smart homes for assistance
por: Haidon, Corentin, et al.
Publicado: (2020)

Religious headwear and alopecia: considerations for dermatologists
por: Alhanshali, Lina, et al.
Publicado: (2023)

Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale
por: Lipton, Richard B., et al.
Publicado: (2017)

Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT‐6) Total and Item‐Specific Scores in Chronic Migraine
por: Houts, Carrie R., et al.
Publicado: (2020)

Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ)
por: Kawata, Ariane K., et al.
Publicado: (2019)

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
por: Rothrock, John F, et al.
Publicado: (2014)

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study
por: Lipton, Richard B., et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on the Wellness of Canadian Plastic Surgery Residents
por: Wong, Chloe R., et al.
Publicado: (2022)

Head, neck, and brain tumor embolization guidelines
por: Duffis, E Jesus, et al.
Publicado: (2012)

Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder
por: Chou, Fabienne, et al.
Publicado: (2016)

History of falls and fear of falling are predictive of future falls: Outcome of a fall rate model applied to the Swiss CHEF Trial cohort
por: Wapp, Christina, et al.
Publicado: (2022)

Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes – The Migraine Functional Impact Questionnaire (MFIQ)
por: Hareendran, Asha, et al.
Publicado: (2018)

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan
por: Kudrow, David, et al.
Publicado: (2020)

Corrigendum: History of falls and fear of falling are predictive of future falls: Outcome of a fall rate model applied to the Swiss CHEF trial cohort
por: Wapp, Christina, et al.
Publicado: (2023)

Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings
por: Denson, Brittany H., et al.
Publicado: (2018)

Intravenous administration of mesenchymal stromal cells leads to a dose-dependent coagulopathy and is unable to attenuate acute traumatic coagulopathy in rats
por: Wu, Xiaowu, et al.
Publicado: (2022)

Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study
por: Gladstone, Jonathan, et al.
Publicado: (2021)

An optimal deep learning framework for multi-type hemorrhagic lesions detection and quantification in head CT images for traumatic brain injury
por: Phaphuangwittayakul, Aniwat, et al.
Publicado: (2021)

Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine‐Associated Nausea and Prior Triptan Use on Efficacy
por: Lipton, Richard B., et al.
Publicado: (2017)

Differences in time-critical interventions and radiological examinations between adult and older trauma patients: A national register-based study
por: Cuevas-Østrem, Mathias, et al.
Publicado: (2022)

Content Validity of a Novel Scar Assessment Tool Evaluating the Career and Sexual Well-being Impact of Scars
por: Garg, Stuti P., et al.
Publicado: (2023)

Live attenuated simian immunodeficiency virus vaccination confers superinfection resistance against macrophage-tropic and neurovirulent wild-type SIV challenge
por: Berry, Neil, et al.
Publicado: (2015)

Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis
por: Blumenfeld, Andrew M., et al.
Publicado: (2021)

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
por: Ailani, Jessica, et al.
Publicado: (2020)

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial
por: Ashina, Messoud, et al.
Publicado: (2023)

A Double-Blind, Placebo-Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine
por: Cady, Roger, et al.
Publicado: (2015)

Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database – A cohort study
por: Zebenholzer, Karin, et al.
Publicado: (2022)

Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention
por: Lipton, Richard B., et al.
Publicado: (2022)

Long‐Term Efficacy of a Double‐Blind, Placebo‐Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx360(®) Device for Treatment of Chronic Migraine
por: Cady, Roger K., et al.
Publicado: (2015)

STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD(®)) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients
por: Smith, Timothy R., et al.
Publicado: (2021)

Implications of providing social support to close network members on the social well-being of older people in Kitui County, Kenya
por: Mbuthia, Kezia, et al.
Publicado: (2022)

Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis
por: Schaetz, Leonhard, et al.
Publicado: (2020)

IMPACT survey: IMpaired fecundity in Physicians and Association with Clinical Time
por: Parsons, Melissa, et al.
Publicado: (2020)

Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II
por: Dodick, David W., et al.
Publicado: (2020)

The migraine signature study: Methods and baseline results
por: Pressman, Alice R., et al.
Publicado: (2020)

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study
por: Silberstein, Stephen D., et al.
Publicado: (2016)

National guideline for the field triage of injured patients: Recommendations of the National Expert Panel on Field Triage, 2021
por: Newgard, Craig D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f9umnnc33rkkimn8s5oebrtrv6